Follow us on
SMS-oncology

News & Events archive

SMS-oncology publishes article Comparison of study designs, objectives and results of Phase I trials with cytotoxic versus non-cytotoxic anticancer agents

SMS-oncology publishes article Comparison of study designs, objectives and results of Phase I trials with cytotoxic versus non-cytotoxic anticancer agents

2 March 2015, Amsterdam

Typical Phase 1 oncology studies have changed and evolved as new techniques have developed, and target therapies have begun to reach the market. By looking at the types of drugs used, the dose levels tested and the patient populations fo...

Read more
SMS-oncology publishes the article "Put to the Test"

SMS-oncology publishes the article "Put to the Test"

26 January 2015, Amsterdam

"Put to the Test", an article by Lindy Bosch and Raymond Hoffmans published in the January issue of EBR, outlines what a typical oncology Phase I study looks like nowadays.

Read more
SMS-oncology launches new website and 4Ds: Drug, Data, Dossier, Direction

SMS-oncology launches new website and 4Ds: Drug, Data, Dossier, Direction

21 January 2015, Amsterdam

SMS-oncology launches new website and 4Ds: Drug, Data, Dossier, Direction

Read more
Edwin Klumper presents at 2nd Antwerp Biopharm Day

Edwin Klumper presents at 2nd Antwerp Biopharm Day

7 November 2013, Amsterdam

Edwin Klumper, Chief Executive Officer at SMS-oncology, presents a talk at the 2nd Antwerp Biopharm Day on the benefits of performing oncology clinical trials in healthy volunteers.

Read more
Eric van der Putten is co-chair and lecturer of workshop Oncology Drug Development in Practice (ODDP)

Eric van der Putten is co-chair and lecturer of workshop Oncology Drug Development in Practice (ODDP)

27 August 2013, Amsterdam

Eric van der Putten will be co-chair and lecturer of the workshop Oncology Drug Development in Practice (ODDP) 2013 which will be held 25-27 November in Amsterdam, The Netherlands.

Read more
SMS-oncology publishes white paper: Personalised Medicine in Cancer Treatment: Hype or Hope?

SMS-oncology publishes white paper: Personalised Medicine in Cancer Treatment: Hype or Hope?

1 January 2012, Amsterdam

Edwin Klumper of SMS-oncology discusses the developments that have taken place in personalised medicine, reviewing the impact they have had on the industry and the challenges that lie ahead.

Read more
Contact us for more information Request for proposal